Your browser doesn't support javascript.
loading
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years.
Paolillo, Stefania; Veglia, Fabrizio; Salvioni, Elisabetta; Corrà, Ugo; Piepoli, Massimo; Lagioia, Rocco; Limongelli, Giuseppe; Sinagra, Gianfranco; Cattadori, Gaia; Scardovi, Angela B; Metra, Marco; Senni, Michele; Bonomi, Alice; Scrutinio, Domenico; Raimondo, Rosa; Emdin, Michele; Magrì, Damiano; Parati, Gianfranco; Re, Federica; Cicoira, Mariantonietta; Minà, Chiara; Correale, Michele; Frigerio, Maria; Bussotti, Maurizio; Battaia, Elisa; Guazzi, Marco; Badagliacca, Roberto; Di Lenarda, Andrea; Maggioni, Aldo; Passino, Claudio; Sciomer, Susanna; Pacileo, Giuseppe; Mapelli, Massimo; Vignati, Carlo; Clemenza, Francesco; Binno, Simone; Lombardi, Carlo; Filardi, Pasquale Perrone; Agostoni, Piergiuseppe.
Afiliação
  • Paolillo S; Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.
  • Veglia F; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Salvioni E; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Corrà U; Division of Cardiac Rehabilitation, Salvatore Maugeri Foundation, IRCCS, Scientific Institute of Veruno, Veruno, Italy.
  • Piepoli M; Division of Cardiology, G. da Saliceto Hospital, Piacenza, Italy.
  • Lagioia R; Division of Cardiology, Salvatore Maugeri Foundation, IRCCS, Scientific Institute of Cassano Murge, Bari, Italy.
  • Limongelli G; Cardiology SUN, Monaldi Hospital (Azienda dei Colli), Second University of Naples, Naples, Italy.
  • Sinagra G; Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy.
  • Cattadori G; Division of Cardiac Rehabilitation, Multimedica IRCCS, Milan, Italy.
  • Scardovi AB; Cardiology Division, Santo Spirito Hospital, Rome, Italy.
  • Metra M; Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Senni M; Department of Cardiology, Heart Failure and Heart Transplant Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Bonomi A; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Scrutinio D; Division of Cardiology, Salvatore Maugeri Foundation, IRCCS, Scientific Institute of Cassano Murge, Bari, Italy.
  • Raimondo R; Salvatore Maugeri Foundation, IRCCS, Scientific Institute of Tradate, Tradate, Italy.
  • Emdin M; Gabriele Monasterio Foundation, CNR-Regione Toscana, Pisa, Italy.
  • Magrì D; Life Science Institute, Scuola Superiore Sant'Anna, Pisa, Italy.
  • Parati G; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Re F; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
  • Cicoira M; Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano, Milan, Italy.
  • Minà C; Cardiology Division, Cardiac Arrhythmia Center and Cardiomyopathies Unit, San Camillo-Forlanini Hospital, Rome, Italy.
  • Correale M; Section of Cardiology, Department of Medicine, University of Verona, Verona, Italy.
  • Frigerio M; Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS - ISMETT, Palermo, Italy.
  • Bussotti M; Department of Cardiology, University of Foggia, Foggia, Italy.
  • Battaia E; 'A. De Gasperis' Cardiology Department, Niguarda Hospital, Milan, Italy.
  • Guazzi M; Cardiac Rehabilitation Unit, Salvatore Maugeri Foundation, IRCCS, Scientific Institute of Milan, Milan, Italy.
  • Badagliacca R; Department of Cardiology, S. Chiara Hospital, Trento, Italy.
  • Di Lenarda A; Cardiology University Department, Heart Failure Unit and Cardiopulmonary Laboratory, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
  • Maggioni A; Department of Cardiovascular Respiratory, Nephrological, Anesthesiological, and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.
  • Passino C; Cardiovascular Center, Health Authority 1 and University of Trieste, Trieste, Italy.
  • Sciomer S; ANMCO Research Center, Florence, Italy.
  • Pacileo G; Gabriele Monasterio Foundation, CNR-Regione Toscana, Pisa, Italy.
  • Mapelli M; Life Science Institute, Scuola Superiore Sant'Anna, Pisa, Italy.
  • Vignati C; Department of Cardiovascular Respiratory, Nephrological, Anesthesiological, and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.
  • Clemenza F; Cardiology SUN, Monaldi Hospital (Azienda dei Colli), Second University of Naples, Naples, Italy.
  • Binno S; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Lombardi C; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Filardi PP; Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS - ISMETT, Palermo, Italy.
  • Agostoni P; Division of Cardiology, G. da Saliceto Hospital, Piacenza, Italy.
Eur J Heart Fail ; 21(2): 208-217, 2019 02.
Article em En | MEDLINE | ID: mdl-30632680
ABSTRACT

AIMS:

Exercise-derived parameters, specifically peak exercise oxygen uptake (peak VO2 ) and minute ventilation/carbon dioxide relationship slope (VE/VCO2 slope), have a pivotal prognostic value in heart failure (HF). It is unknown how the prognostic threshold of peak VO2 and VE/VCO2 slope has changed over the last 20 years in parallel with HF prognosis improvement. METHODS AND

RESULTS:

Data from 6083 HF patients (81% male, age 61 ± 13 years), enrolled in the MECKI score database between 1993 and 2015, were retrospectively analysed. By enrolment year, four groups were generated group 1 1993-2000 (n = 440), group 2 2001-2005 (n = 1288), group 3 2006-2010 (n = 2368), and group 4 2011-2015 (n = 1987). We compared the 10-year survival of groups and analysed how the overall risk (cardiovascular death, urgent heart transplantation, or left ventricular assist device implantation) changed over time according to peak VO2 and VE/VCO2 slope and to major clinical and therapeutic variables. At 10 years, a progressively higher survival from group 1 to group 3 was observed, with no further improvement afterwards. A 20% risk for peak VO2 15 mL/min/kg (95% confidence interval 16-13), 9 (11-8), 4 (4-2) and 5 (7-4) was observed in group 1, 2, 3, and 4, respectively, while the VE/VCO2 slope value for a 20% risk was 32 (37-29), 47 (51-43), 59 (64-55), and 57 (63-52), respectively.

CONCLUSIONS:

Heart failure prognosis improved over time up to 2010 in a HF population followed by experienced centres. The peak VO2 and VE/VCO2 slope cut-offs identifying a definite risk progressively decreased and increased over time, respectively. The prognostic threshold of peak VO2 and VE/VCO2 slope must be updated whenever HF prognosis improves.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Consumo de Oxigênio / Ventilação Pulmonar / Previsões / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Consumo de Oxigênio / Ventilação Pulmonar / Previsões / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article